The Infant Formula and Follow-on Formula (Wales) (Amendment) Regulations 2021

JurisdictionWales
CitationSI 2021/955 (W219)

2021 No. 955 (W. 219)

Food, WalesFood Safety

The Infant Formula and Follow-on Formula (Wales) (Amendment) Regulations 2021

Made 25th August 2021

Laid before Senedd Cymru 26th August 2021

Coming into force 16th September 2021

The Welsh Ministers make the following Regulations in exercise of the powers conferred by sections 6(4), 16(1)(a) and (e) and (2)(b), 17(1) and (2), 26(1) and (3) and 48(1) of the Food Safety Act 19901and now vested in them2.

The Welsh Ministers have had regard to relevant advice given by the Food Standards Agency in accordance with section 48(4A) of the Food Safety Act 19903.

There has been open and transparent public consultation as required by Article 9 of Regulation (EC) No. 178/2002of the European Parliament and of the Council laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety4, during the preparation and evaluation of these Regulations.

S-1 Title and commencement

Title and commencement

1.—(1) The title of these Regulations is the Infant Formula and Follow-on Formula (Wales) (Amendment) Regulations 2021.

(2) These Regulations come into force on 16 September 2021.

S-2 Amendment of the Infant Formula and Follow-on Formula (Wales) Regulations 2020

Amendment of the Infant Formula and Follow-on Formula (Wales) Regulations 2020

2.—(1) The Infant Formula and Follow-on Formula (Wales) Regulations 20205are amended as follows.

(2) After regulation 5(3) (revocations, savings and transitional provisions) insert—

S-4

“4 Regulations 2 to 4 do not apply in respect of infant formula and follow-on formula manufactured from protein hydrolysates until 22 February 2022.

S-5

5 Schedule 4 makes provision in relation to infant formula and follow-on formula manufactured from protein hydrolysates until 22 February 2022.”

(3) After Schedule 3 (Revocations relating to Infant Formula and Follow-on Formula) insert the new Schedule 4 set out in the Schedule to these Regulations.

Lynne Neagle

Deputy Minister for Mental Health and Wellbeing under authority of the Minister for Health and Social Services, one of the Welsh Ministers

25 August 2021

SCHEDULE

Regulation 2(3)

SCHEDULE

SCHEDULE 4

Regulation 5(5)

Regulation of infant formula and follow-on formula manufactured from protein hydrolysates until 22 February 2022

Interpretation

In this Schedule—

“the Act” (“y Ddeddf”) means the Food Safety Act 1990;

“the Directive” (“y Gyfarwyddeb”) means Commission Directive 2006/141/EC6on infant formulae and follow-on formulae and amending Directive 1999/21/EC;

“follow-on formula” (“fformiwla ddilynol”) means foodstuffs intended for particular nutritional use by infants when appropriate complementary feeding is introduced and constituting the principal liquid element in a progressively diversified diet of such infants;

“food authority” (“awdurdod bwyd”) has the meaning that it bears by virtue of section 5(1A) of the Act7;

“health care system” (“system gofal iechyd”) means institutions or organisations engaged, directly or indirectly, in health care for mothers, infants and pregnant women, including nurseries or child care institutions and health workers in private practice;

“infant formula” (“fformiwla fabanod”) means foodstuffs intended for particular nutritional use by infants during the first months of life and satisfying by themselves the nutritional requirements of such infants until the introduction of appropriate complementary feeding;

“infants” (“babanod”) means children under the age of 12 months;

“young children” (“plant ifanc”) means children aged between one and three years.

Subject to sub-paragraph (3), any expression other than one defined in sub-paragraph (1) that is used both in this Schedule and in the Act has the meaning it bears in the Act.

Any expression used both in this Schedule and in the Directive has the meaning that it bears in the Directive.

In this Schedule, any reference to a numbered Annex is a reference to the Annex bearing that number in the Directive.

Prohibition on the marketing of infant formula or follow-on formula unless certain conditions are met

No person may market infant formula which contravenes or fails to comply with paragraph 4, 5, 7, 9, 10, 11, 13(1), (2) or (3), 14, 16, 18 or 19(1).

No person may market follow-on formula which contravenes or fails to comply with paragraph 4, 6, 8, 9, 10, 11, 13(1), (2) or (3), 15, 17, 18 or 19(2).

Prohibition on the marketing of products other than infant formula for normal healthy infants

No person may market or otherwise represent a product as suitable for satisfying by itself the nutritional requirements of normal healthy infants during the first months of life until the introduction of appropriate complementary feeding unless that product is infant formula.

Substances in such quantity as to endanger the health of infants and young children

Infant formula and follow-on formula must not contain any substance in such quantity as to endanger the health of infants and young children.

Protein hydrolysates and other food ingredients suitable for infants from birth (infant formula)

Infant formula must be manufactured from—

protein hydrolysates; and

other food ingredients the suitability of which for particular nutritional use by infants from birth has been established by generally accepted scientific data and demonstrated in accordance with sub-paragraph (2).

Suitability is to be demonstrated through a systematic review of the available data relating to the expected benefits and to safety considerations as well as, where necessary, appropriate studies, performed following generally accepted expert guidance on the design and conduct of such studies.

Protein hydrolysates and other food ingredients suitable for infants aged over 6 months (follow-on formula)

Follow-on formula must be manufactured from—

protein hydrolysates; and

other food ingredients the suitability of which for particular nutritional use by infants aged over 6 months has been established by generally accepted scientific data and demonstrated in accordance with paragraph 5(2).

Compositional criteria for infant formula

Subject to sub-paragraph (2), infant formula must comply with the compositional criteria set out in Annex I taking into account the specifications in Annex V.

In the case of infant formula manufactured from protein hydrolysates specified in point 2.2 of Annex I with a protein content between the minimum and 0.56g/100kJ (2.25g/100 kcal)—

the suitability of the infant formula for the particular nutritional use by infants must be demonstrated through appropriate studies, performed following generally accepted expert guidance on the design and conduct of such studies; and

the infant formula must be in accordance with the appropriate specifications set out in Annex VI.

Compositional criteria for follow-on formula

Subject to sub-paragraph (2), follow-on formula must comply with the compositional criteria set out in Annex II taking into account the specifications set out in Annex V.

In the case of follow-on formula manufactured from those protein hydrolysates specified in point 2.2 of Annex II with a protein content between the minimum and 0.56g/100kJ (2.25g/100kcal)—

the suitability of the follow-on formula for satisfying the nutritional requirements of normal healthy infants in conjunction with complementary feeding must be demonstrated through appropriate studies, performed following generally accepted expert guidance on the design and conduct of such studies; and

the follow-on formula must be in accordance with the appropriate specifications set out in Annex VI.

Addition of water (infant formula and follow-on formula)

In order to make infant formula or follow-on formula ready for use nothing more must be required than the addition of water.

Prohibitions and limitations on the use of food ingredients (infant formula and follow-on formula)

The prohibitions and limitations on the use of food ingredients in infant formula and follow-on formula, set out respectively in Annexes I and II, must be observed.

Listed substances and their purity criteria (infant formula and follow-on formula)

Only the substances listed in Annex III may be used in the manufacture of infant formula and follow-on formula in order to satisfy the requirements of Annexes I and II respectively on—

mineral substances;

vitamins;

amino acids and other nitrogen compounds; and

other substances having a particular nutritional purpose.

Substances used in the manufacture of infant formula and follow-on formula pursuant to sub-paragraph (1) must meet the relevant purity criteria.

The relevant purity criteria for the purposes of sub-paragraph (2) are—

the purity criteria for substances, as provided for in retained EU law concerning the use of substances listed in Annex III, in the manufacture of foodstuffs for purposes other than those covered by the Directive; and

in the absence of such purity criteria, generally acceptable purity criteria recommended by international bodies.

Notification of infant formula

No food business operator may place an infant formula on the market in Wales that has not yet been placed on the market in the United Kingdom unless the food business operator has given prior notice to the Welsh Ministers by forwarding to them a model of the label used for the product.

Pesticide residues (infant formula and follow-on formula)

Subject to sub-paragraphs (2) and (3), infant formula and follow-on formula must not contain residues of individual pesticides at...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT